This is a preview of subscription content, log in via an institution to check access.
Notes
including low BP, increased/decreased heart rate, shortness of breath, wheezing, angioedema, difficulty swallowing, rash, nausea, vomiting, sweating, shivering and respiratory distress.
Reference
US Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use. Internet Document : 15 Jun 2020. Available from: URL: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-warns-newly-discovered-potential-drug-interaction-may-reduce
Rights and permissions
About this article
Cite this article
New potential interaction with emergency COVID-19 medicine remdesivir. Reactions Weekly 1810, 3 (2020). https://doi.org/10.1007/s40278-020-80023-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80023-6